Explore evidence

37.3 %The prevalence of delayed presentation in this study is 37.3%.

Nigeriapaludismepublished 2022The Nigerian postgraduate medical journalPubMeddocument of 4 observations

The Pfmdr1 haplotype 86N-184F-1246D was selected for among posttreatment samples obtained from patients with newly acquired or recrudescing infections after treatment with artemether-lumefantrine.

Nigeriapaludismepublished 2009Antimicrobial agents and chemotherapyeurope_pmcdocument of 5 observationsDOI 10.1128/aac.00968-08

10.7 hIntramuscular artemether given for five days resulted in a fever clearance time of 10.7 hours with a standard deviation of 3.6 hours (range 6–24 hours) in 32 patients with acute recrudescent Plasmodium falciparum malaria.

Nigeriapaludismepublished 1997Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observations

8.3 %The Pfmdr1-1246Y mutation prevalence was 8.3% in asymptomatic malaria cases (3/36) among children in Ibadan, Southwest Nigeria.

Nigeriapaludismeobserved 2016–2021published 2025Scientific reportsPubMeddocument of 5 observations

93.6 %Negative predictive value of CareStart™ for malaria diagnosis was 93.6%.

Nigeriapaludismepublished 2016Malaria research and treatmenteurope_pmcdocument of 14 observations

95.2 %Plasmodium falciparum was seen in 95.2% of the malaria cases as either mixed infection with P. malariae (3.6%) or as a mono infection (91.6%).

Nigeriapaludismepublished 2013Infectious diseases of povertyeurope_pmcdocument of 6 observationsDOI 10.1186/2049-9957-2-19

100 %The cure rate was 100% on days 14 and 28 with mefloquine.

Nigeriapaludismepublished 1997Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 6 observations

5.88 %Neonatal cord blood parasitaemia prevalence was 5.88% among women who took sulfadoxine-pyrimethamine twice.

Nigeriapaludismepublished 2022African health sciencesPubMeddocument of 22 observations

5.7 %Overall, mean deficit in haematocrit from baseline (DIHFB) was 5.7% 7 days after treatment initiation in children with malaria treated with artemisinin-based combination treatments.

Nigeriapaludismepublished 2019Parasite (Paris, France)europe_pmcdocument of 5 observationsDOI 10.1051/parasite/2019058

3.22 USDThe programmatic economic cost of delivering an insecticide-treated net (ITN) to a household was estimated at $3.22 in Ondo State, Nigeria.

Nigeriapaludismepublished 2026Malaria journalPubMeddocument of 10 observations

93.5 %43 (93.5%) RBM focal persons in Benue State found it easy to fill the standardized malaria data tools.

Nigeriapaludismepublished 2022Malaria journalPubMeddocument of 10 observations

1.7 odds_ratioIn adjusted analyses, microscopy detectable gametocytemia at enrolment was associated with an increase in the odds of IgG seropositivity to Pf s230D1M (OR 1.70 [95% CI 1.03, 2.80], p = 0.037).

Nigeriapaludismepublished 2022Frontiers in cellular and infection microbiologyeurope_pmcdocument of 7 observations

There was a significant prolongation in both the prothrombin time and activated partial thromboplastin time among the malaria parasitized pregnant subjects compared to the non-parasitized controls (p = 0.000).

Nigeriapaludismepublished 2020Human antibodiesPubMeddocument of 2 observations

30.3 %30.30% of age-ineligible children sampled received at least one dose of seasonal malaria chemoprevention (SMC) medicines in Nigeria during the 2022 round.

Nigeriapaludismeobserved 2022published 2024Malaria journalPubMeddocument of 2 observations

25 %The prevalence of malaria infection was 25.0% among pregnant women in their first pregnancy.

Nigeriapaludismepublished 2020Malaria journalPubMeddocument of 7 observations

5.6 %Gametocytemia was detected in 62 patients (5.6% after treatment).

Nigeriapaludismepublished 2007Antimicrobial agents and chemotherapyeurope_pmcdocument of 4 observations

0 %Cord blood malaria was 0% in the study population.

Nigeriapaludismepublished 2025Scientific reportsPubMeddocument of 5 observations

15.7 %Among 1310 children under 5 years of age in Ebonyi state, Nigeria, caregivers of 82 (15.7%) requested malaria rapid diagnostic test (MRDT).

Nigeriapaludismeobserved 2018published 2021BMC health services researchPubMeddocument of 9 observations

21.2 nML'IC50 de l'artémisinine sur la souche Dd2 (résistante à la chloroquine) est de 21,2 ± 2,3 nM.

Nigeriapaludismeobserved 2013HAL · Unilimdocument of 173 observations

2.23 daysThe mean parasite clearance time was 2.23 days in the sulphadoxine-pyrimethamine group.

Nigeriapaludismepublished 1992Annals of Tropical Medicine and ParasitologyOpenAlexdocument of 19 observations

67.4 %Child protection was cited as a driver of malaria vaccine acceptance by 67.4% of caregivers.

Nigeriapaludismeobserved 2025PubMeddocument of 9 observations

97.3 %An overwhelming 366 participants (97.3%) expressed willingness to vaccinate their children against malaria.

Nigeriapaludismepublished 2025BMJ openPubMeddocument of 4 observations

7 casesSeven previously healthy, non-immunocompromised adolescents and adults with cerebral malaria were seen over a nine-month period in an endemic area.

Nigeriapaludismepublished 1993PubMedOpenAlexdocument of 7 observations

7.61 x 10^9/LChildren without parasitaemia had total leukocyte counts of 7.61 +/- 4.11 x 10(9)/L, compared with 9.04 +/- 5.0 x 10(9)/L in children with parasitaemia.

Nigeriapaludismepublished 1995PubMedOpenAlexdocument of 4 observations

531,228,984 USDUS$ 531,228,984 (47.3%) of the needed funds for national malaria interventions in Nigeria from 2018 to 2020 were funded.

Nigeriapaludismeobserved 2018-2020published 2023A Conceptual Framework on the Role of Backward Integration in Sustainable Access to Malarieurope_pmcdocument of 9 observationsDOI 10.21203/rs.3.rs-2963622/v1